Molecular Genetics of Mental Disorders
	Pierre Fabre Research Institute , Castres, France 23 to 26 November 1999
	Topics will include: Experimental Approaches in Molecular Genetics of Mental Disorders · Gene knock-out techniques · Antisense technology · Transitory and permanent gene transfection into cell lines · Quantitative hybridisation of high density cDNA arrays · Differential display for detecting potential gene candidates · Orphan receptors as drug targets · Validation of a receptor as a drug target · 5-HT modulin, an example of the integration of molecular genetic tools Gene expression, Gene Polymorphism and linkage studies · Effect of antidepressants on gene expression · Genomics for discovering new targets · Constitutively active receptors - a particular aspect of polymorphism · Polymorphism of the 5-HT transporter and psychiatric disorders · Suicide, alcoholism and tryptophan hydroxylase polymorphism · Polymorphism of the enzymes involved in monoamine synthesis · Pharmacogenetics of Schizophrenia · Apolipoprotein E and the susceptibility to neurodegenerative disease Molecular genetics in therapeutic practice · Gene therapy - The dream, the nightmare, and the reality · How will molecular genetics change the practice of psychiatry and neurology?
	Organized by:	Mike Briley
	Invited Speakers:	O. Civelli (Switzerland) D. Cohen (France) S. Cotecchia (Switzerland) R.S. Duman (USA) G. Fillion (France) R. Hen (USA) A. Kahn (France) KP. Lesch (Germany) J. Mallet (France) DA. Nielsen (USA) D. Nutt (UK) P. Pauwels (France) D. Pickar (USA) G. Pietu (France) J. Sallinen (Finland) WJ. Strittmatter (USA) F. Sulser (USA)
	Deadline for Abstracts:	31 july 1999
	Registration:	Carte Blanche 19 rue Mahuzies 81100 castres France Email cbo@carte-blanche.fr tel (33)563723100 fax (33)563723032
	Email for Requests and Registration:	cbo@carte-blanche.fr
	Posted by: Mike Briley   Host: cyber44.national.imaginet.fr date: September 29, 1998 12:51:13 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.